Literature DB >> 19940279

The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors.

Christine Seminatore1, Jerome Polentes, Ditte Ellman, Nataliya Kozubenko, Valerie Itier, Samir Tine, Laurent Tritschler, Marion Brenot, Emmanuelle Guidou, Johanna Blondeau, Mickael Lhuillier, Aurore Bugi, Laetitia Aubry, Pavla Jendelova, Eva Sykova, Anselme L Perrier, Bente Finsen, Brigitte Onteniente.   

Abstract

BACKGROUND AND
PURPOSE: Risk of tumorigenesis is a major obstacle to human embryonic and induced pluripotent stem cell therapy. Likely linked to the stage of differentiation of the cells at the time of implantation, formation of teratoma/tumors can also be influenced by factors released by the host tissue. We have analyzed the relative effects of the stage of differentiation and the postischemic environment on the formation of adverse structures by transplanted human embryonic stem cell-derived neural progenitors.
METHODS: Four differentiation stages were identified on the basis of quantitative polymerase chain reaction expression of pluripotency, proliferation, and differentiation markers. Neural progenitors were transplanted at these 4 stages into rats with no, small, or large middle cerebral artery occlusion lesions. The fate of each transplant was compared with their pretransplantation status 1 to 4 months posttransplantation.
RESULTS: The influence of the postischemic environment was limited to graft survival and occurrence of nonneuroectodermal structures after transplantation of very immature neural progenitors. Both effects were lost with differentiation. We identified a particular stage of differentiation characterized in vitro by a rebound of proliferative activity that produced highly proliferative grafts susceptible to threaten surrounding host tissues.
CONCLUSIONS: The effects of the ischemic environment on the formation of teratoma by transplanted human embryonic stem cell-derived neural progenitors are limited to early differentiation stages that will likely not be used for stem cell therapy. In contrast, hyperproliferation observed at later stages of differentiation corresponds to an intrinsic activity that should be monitored to avoid tumorigenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19940279     DOI: 10.1161/STROKEAHA.109.563015

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  56 in total

Review 1.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

Review 2.  Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.

Authors:  Issei S Shimada; Jeffrey L Spees
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

Review 3.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

4.  Tracing synaptic connectivity onto embryonic stem cell-derived neurons.

Authors:  Isabella Garcia; Longwen Huang; Kevin Ung; Benjamin R Arenkiel
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

Review 5.  Cross-talk between neural stem cells and immune cells: the key to better brain repair?

Authors:  Zaal Kokaia; Gianvito Martino; Michal Schwartz; Olle Lindvall
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

6.  Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy.

Authors:  Xu Maisano; Elizabeth Litvina; Stephanie Tagliatela; Gloster B Aaron; Laura B Grabel; Janice R Naegele
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

7.  WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors.

Authors:  Lu Cui; Yuan Guan; Zepeng Qu; Jingfa Zhang; Bing Liao; Bo Ma; Jiang Qian; Dangsheng Li; Weiye Li; Guo-Tong Xu; Ying Jin
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 8.  Stem cell-based neuroprotective and neurorestorative strategies.

Authors:  Chia-Wei Hung; Ying-Jay Liou; Shao-Wei Lu; Ling-Ming Tseng; Chung-Lan Kao; Shih-Jen Chen; Shih-Hwa Chiou; Charn-Jung Chang
Journal:  Int J Mol Sci       Date:  2010-05-05       Impact factor: 5.923

9.  Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling.

Authors:  Kate M Harms; Lu Li; Lee Anna Cunningham
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 10.  Genomic instability in pluripotent stem cells: implications for clinical applications.

Authors:  Suzanne E Peterson; Jeanne F Loring
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.